Screener
Cullinan Therapeutics, Inc. CGEM EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Cullinan Therapeutics, Inc.’s 10-Q, filed November 7, 2024. Open the filing →
- Filed
- Nov 7, 2024
- Fiscal quarter
- Q3 FY2024
- Calendar quarter
- Q3 2024
- Accession
- 0000950170-24-122795
FAQ
- What is Cullinan Therapeutics, Inc.'s EPS (diluted)?
- Cullinan Therapeutics, Inc. (CGEM) reported EPS (diluted) of -$0.69 in Q3 2024.
- How has Cullinan Therapeutics, Inc.'s EPS (diluted) changed year-over-year?
- Cullinan Therapeutics, Inc.'s EPS (diluted) increased by 24.2% year-over-year, from -$0.91 to -$0.69.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Cullinan Therapeutics, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude